Gian-Gabriel P. Garcia, L. Steimle, Wesley J. Marrero, J. Sussman
{"title":"高血压治疗计划的可解释性政策和可解释性的代价","authors":"Gian-Gabriel P. Garcia, L. Steimle, Wesley J. Marrero, J. Sussman","doi":"10.1287/msom.2021.0373","DOIUrl":null,"url":null,"abstract":"Problem definition: Effective hypertension management is critical to reducing the consequences of atherosclerotic cardiovascular disease, a leading cause of death in the United States. Clinical guidelines for hypertension can be enhanced using decision-analytic approaches capable of capturing complexities in treatment planning. However, model-generated recommendations may be uninterpretable/unintuitive, limiting their clinical acceptability. We address this challenge by investigating interpretable treatment plans. Methodology/results: We formulate interpretable treatment plans as Markov decision processes (MDPs) and analyze the problems of optimizing monotone policies, which prohibit decreasing treatment intensity for sicker patients, and class-ordered monotone policies, which generalize monotone policies. We establish that both policies depend on initial state distributions and that optimal monotone policies can be generated tractably for many treatment planning problems. Next, we propose exact formulations for optimizing interpretable policies broadly. Then, we analyze the price of interpretability, proving that the class-ordered monotone policy’s price of interpretability does not exceed the monotone policy’s price of interpretability. Finally, we formulate and evaluate MDPs for hypertension treatment planning using a large nationally representative data set of the U.S. population. We compare the structure and performance of optimal monotone policies and class-ordered monotone policies with optimal MDP-based policies and current clinical guidelines. At the patient level, optimal MDP-based policies may be unintuitive, recommending more aggressive treatment for healthier patients than sicker patients. Conversely, monotone policies and class-ordered monotone policies never deescalate treatment, reflecting clinical intuition. Across 66.5 million patients, optimized monotone policies and class-ordered monotone policies outperform clinical guidelines, saving over 3,246 quality-adjusted life years per 100,000 patients, with both policies paying a low price of interpretability. Sensitivity analysis illustrates that monotone policies and class-ordered monotone policies are robust to various definitions of “interpretability.” Managerial implications: Interpretable policies can be tractably optimized, drastically outperform existing guidelines, and perform near optimally—potentially increasing the acceptability of decision-analytic approaches in practice. Funding: L. N. Steimle and W. J. Marrero received support from the National Science Foundation Graduate Research Fellowship [Grant DGE 1256260]. J. B. Sussman received support from the National Institutes of Health [Grants R01NS102715 and RF1AG068410], the U.S. Department of Veterans Affairs [Grants 1I01-HX003304 and 1I50-HX003251], and the Michigan Department of Health and Human Services. Supplemental Material: The e-companion is available at https://doi.org/10.1287/msom.2021.0373 .","PeriodicalId":119284,"journal":{"name":"Manufacturing & Service Operations Management","volume":"62 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":"{\"title\":\"Interpretable Policies and the Price of Interpretability in Hypertension Treatment Planning\",\"authors\":\"Gian-Gabriel P. Garcia, L. Steimle, Wesley J. Marrero, J. Sussman\",\"doi\":\"10.1287/msom.2021.0373\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Problem definition: Effective hypertension management is critical to reducing the consequences of atherosclerotic cardiovascular disease, a leading cause of death in the United States. Clinical guidelines for hypertension can be enhanced using decision-analytic approaches capable of capturing complexities in treatment planning. However, model-generated recommendations may be uninterpretable/unintuitive, limiting their clinical acceptability. We address this challenge by investigating interpretable treatment plans. Methodology/results: We formulate interpretable treatment plans as Markov decision processes (MDPs) and analyze the problems of optimizing monotone policies, which prohibit decreasing treatment intensity for sicker patients, and class-ordered monotone policies, which generalize monotone policies. We establish that both policies depend on initial state distributions and that optimal monotone policies can be generated tractably for many treatment planning problems. Next, we propose exact formulations for optimizing interpretable policies broadly. Then, we analyze the price of interpretability, proving that the class-ordered monotone policy’s price of interpretability does not exceed the monotone policy’s price of interpretability. Finally, we formulate and evaluate MDPs for hypertension treatment planning using a large nationally representative data set of the U.S. population. We compare the structure and performance of optimal monotone policies and class-ordered monotone policies with optimal MDP-based policies and current clinical guidelines. At the patient level, optimal MDP-based policies may be unintuitive, recommending more aggressive treatment for healthier patients than sicker patients. Conversely, monotone policies and class-ordered monotone policies never deescalate treatment, reflecting clinical intuition. Across 66.5 million patients, optimized monotone policies and class-ordered monotone policies outperform clinical guidelines, saving over 3,246 quality-adjusted life years per 100,000 patients, with both policies paying a low price of interpretability. Sensitivity analysis illustrates that monotone policies and class-ordered monotone policies are robust to various definitions of “interpretability.” Managerial implications: Interpretable policies can be tractably optimized, drastically outperform existing guidelines, and perform near optimally—potentially increasing the acceptability of decision-analytic approaches in practice. Funding: L. N. Steimle and W. J. Marrero received support from the National Science Foundation Graduate Research Fellowship [Grant DGE 1256260]. J. B. Sussman received support from the National Institutes of Health [Grants R01NS102715 and RF1AG068410], the U.S. Department of Veterans Affairs [Grants 1I01-HX003304 and 1I50-HX003251], and the Michigan Department of Health and Human Services. Supplemental Material: The e-companion is available at https://doi.org/10.1287/msom.2021.0373 .\",\"PeriodicalId\":119284,\"journal\":{\"name\":\"Manufacturing & Service Operations Management\",\"volume\":\"62 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Manufacturing & Service Operations Management\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1287/msom.2021.0373\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Manufacturing & Service Operations Management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1287/msom.2021.0373","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4
摘要
问题定义:有效的高血压管理对于减少动脉粥样硬化性心血管疾病的后果至关重要,动脉粥样硬化性心血管疾病是美国的主要死亡原因。高血压的临床指南可以通过决策分析方法来加强,这些决策分析方法能够捕捉到治疗计划中的复杂性。然而,模型生成的建议可能无法解释/不直观,限制了它们的临床可接受性。我们通过研究可解释的治疗方案来解决这一挑战。方法/结果:我们将可解释的治疗计划制定为马尔可夫决策过程(mdp),并分析了单调政策的优化问题,单调政策禁止对病情较重的患者降低治疗强度,类有序单调政策推广单调政策。我们建立了这两种策略都依赖于初始状态分布,并且对于许多治疗计划问题可以生成可跟踪的最优单调策略。接下来,我们提出了广泛优化可解释策略的精确公式。然后,我们分析了可解释性的价格,证明了类序单调策略的可解释性价格不超过单调策略的可解释性价格。最后,我们使用具有全国代表性的美国人口数据集来制定和评估高血压治疗计划的mdp。我们比较了最优单调策略和类有序单调策略的结构和性能,以及基于mdp的最优策略和当前临床指南。在患者层面,基于mdp的最佳政策可能不直观,建议对健康的患者进行比病情较重的患者更积极的治疗。相反,单调政策和分类有序单调政策从不降低治疗的级别,这反映了临床直觉。在6650万名患者中,优化的单调政策和分类有序的单调政策优于临床指南,每10万名患者节省了3246个质量调整生命年,两种政策的可解释性都很低。敏感性分析表明,单调策略和类有序单调策略对各种“可解释性”定义都具有鲁棒性。管理意义:可解释的策略可以被跟踪优化,大大超过现有的指导方针,并执行接近最优-潜在地增加决策分析方法在实践中的可接受性。资助:L. N. Steimle和W. J. Marrero获得了美国国家科学基金会研究生研究奖学金[Grant DGE 1256260]的支持。J. B. Sussman得到了美国国立卫生研究院[赠款R01NS102715和RF1AG068410]、美国退伍军人事务部[赠款1I01-HX003304和1I50-HX003251]和密歇根州卫生与公众服务部的支持。补充材料:电子伴侣可在https://doi.org/10.1287/msom.2021.0373上获得。
Interpretable Policies and the Price of Interpretability in Hypertension Treatment Planning
Problem definition: Effective hypertension management is critical to reducing the consequences of atherosclerotic cardiovascular disease, a leading cause of death in the United States. Clinical guidelines for hypertension can be enhanced using decision-analytic approaches capable of capturing complexities in treatment planning. However, model-generated recommendations may be uninterpretable/unintuitive, limiting their clinical acceptability. We address this challenge by investigating interpretable treatment plans. Methodology/results: We formulate interpretable treatment plans as Markov decision processes (MDPs) and analyze the problems of optimizing monotone policies, which prohibit decreasing treatment intensity for sicker patients, and class-ordered monotone policies, which generalize monotone policies. We establish that both policies depend on initial state distributions and that optimal monotone policies can be generated tractably for many treatment planning problems. Next, we propose exact formulations for optimizing interpretable policies broadly. Then, we analyze the price of interpretability, proving that the class-ordered monotone policy’s price of interpretability does not exceed the monotone policy’s price of interpretability. Finally, we formulate and evaluate MDPs for hypertension treatment planning using a large nationally representative data set of the U.S. population. We compare the structure and performance of optimal monotone policies and class-ordered monotone policies with optimal MDP-based policies and current clinical guidelines. At the patient level, optimal MDP-based policies may be unintuitive, recommending more aggressive treatment for healthier patients than sicker patients. Conversely, monotone policies and class-ordered monotone policies never deescalate treatment, reflecting clinical intuition. Across 66.5 million patients, optimized monotone policies and class-ordered monotone policies outperform clinical guidelines, saving over 3,246 quality-adjusted life years per 100,000 patients, with both policies paying a low price of interpretability. Sensitivity analysis illustrates that monotone policies and class-ordered monotone policies are robust to various definitions of “interpretability.” Managerial implications: Interpretable policies can be tractably optimized, drastically outperform existing guidelines, and perform near optimally—potentially increasing the acceptability of decision-analytic approaches in practice. Funding: L. N. Steimle and W. J. Marrero received support from the National Science Foundation Graduate Research Fellowship [Grant DGE 1256260]. J. B. Sussman received support from the National Institutes of Health [Grants R01NS102715 and RF1AG068410], the U.S. Department of Veterans Affairs [Grants 1I01-HX003304 and 1I50-HX003251], and the Michigan Department of Health and Human Services. Supplemental Material: The e-companion is available at https://doi.org/10.1287/msom.2021.0373 .